Oxadiazole derivatives as DGAT inhibitors

Details for Australian Patent Application No. 2010206031 (hide)

Owner AstraZeneca AB

Inventors Butlin, Roger John; Birch, Alan Martin; McCoull, William; Plowright, Alleyn; Donald, Craig Samuel; Bowker, Suzanne Saxon; Nowak, Thorsten

Agent Davies Collison Cave

Pub. Number AU-A-2010206031

Parent 2005315430

Filing date 28 July 2010

Wipo publication date 19 August 2010

International Classifications

C07D 271/10 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

19 August 2010 Application Open to Public Inspection

  Published as AU-A-2010206031

19 August 2010 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010206032-Methods of treating patients having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension

2010206030-Client-Server Electronic Program Guide